Login / Signup

Prevalence of psychotropic medication dispensing to people living with cystic fibrosis in Australia: 2013-2022.

Louise LordPeter WarkMark HewBrooke BlakeleyMichelle SteeperSue KirsaJenni Ilomäki
Published in: Journal of psychosomatic research (2024)
Psychotropic medication use is higher among Australian PwCF compared to the general population, with varying prevalence across age and sex groups. This is of interest due to complexities with CF comorbidities and potential medication influences and interactions. Future studies should investigate the reasons for psychotropic use disparities within PwCF with the aim to establish targeted guidelines and optimize outcomes.
Keyphrases
  • risk factors
  • healthcare
  • cystic fibrosis
  • adverse drug
  • type diabetes
  • drug delivery
  • human health
  • skeletal muscle
  • metabolic syndrome
  • electronic health record
  • weight loss
  • drug induced